Boston Scientific price target cut by Bear

Boston Scientific Corp. was maintained by Bear Stearns analyst Rick Wise at an outperform rating, but the price target on the stock was lowered to $30 per share from $33 following the company's warning of softer third-quarter results because of sluggish August sales, particularly in the cardiovascular division. Boston Scientific shares Thursday were up $0.92, or 3.79%, at $25.18 on volume of 11,833,100 shares versus the three-month running average of 4,056,080 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.